Affiliation:
1. Pharma Nord (UK) Ltd., Morpeth NE61 2DB, UK
2. School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK
Abstract
Some 90 autoimmune disorders have been described in medical literature, affecting most of the tissues within the body. Autoimmune disorders may be difficult to treat, and there is a need to develop novel therapeutic strategies for these disorders. Autoimmune disorders are characterised by mitochondrial dysfunction, oxidative stress, and inflammation; there is therefore a rationale for a role for coenzyme Q10 in the management of these disorders, on the basis of its key role in normal mitochondrial function, as an antioxidant, and as an anti-inflammatory agent. In this article, we have therefore reviewed the potential role of CoQ10, in terms of both deficiency and/or supplementation, in a range of autoimmune disorders.
Reference112 articles.
1. Pathogenesis of autoimmune disease;Pisetsky;Nat. Rev. Nephrol.,2023
2. Samuels, H., Malov, M., Saha Detroja, T., Ben Zaken, K., Bloch, N., Gal-Tanamy, M., Avni, O., Polis, B., and Samson, A.O. (2022). Autoimmune Disease Classification Based on PubMed Text Mining. J. Clin. Med., 11.
3. Autoimmune pre-disease;Bieber;Autoimmun. Rev.,2023
4. Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: Potential role in Sjögren’s syndrome;Barrera;Autoimmun. Rev.,2021
5. IRGM1 links mitochondrial quality control to autoimmunity;Rai;Nat. Immunol.,2021